News Search

Category: Corporate Alliances

Jean Bennett, M.D., Ph.D., joins REGENXBIO Board of Directors

She will serve as a member of REGENXBIO's Nominating and Corporate Governance Committee. 

iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing

The biotech will use the funds for a slate of gene insertion programs for liver disorders out of the lab of gene therapy pioneer Jim Wilson, M.D., Ph.D. at Penn.

COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval

The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.

Listen: The Unlikely Pioneer Behind mRNA Vaccines

The Daily podcast by the New York Times interviewed Dr. Katalin Kariko about the long road to getting mRNA into the vaccines that are winning the war against COVID.

PCI’s Managing Director leads panel discussion on Cellicon Valley with Penn Medicine faculty luminaries

On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology

Filter

Skip to content